Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

K
Kaal, Suzanne

Radboud University Medical Center
(P 319) THE SURVIVAL DISPARITY BETWEEN CHILDREN AND ADOLESCENTS & YOUNG ADULTS WITH EWING SARCOMA IN THE NETHERLANDS DID NOT CHANGE SINCE THE 1990S DESPITE IMPROVED SURVIVAL: A POPULATION-BASED STUDY
Suzanne Kaal
Favorite
Kaczkofsky, Brynn

University of Michigan
(P 131) HETEROGENEITY OF THE IMMUNE MICROENVIRONMENT AND IMMUNOTHERAPY RESPONSE IN A DEDIFFERENTIATED LIPOSARCOMA MOUSE MODEL
Brynn Kaczkofsky
Favorite
(P 341) THE EFFECTS OF ULTRASOUND-GUIDED HISTOTRIPSY ON SOFT TISSUE SARCOMA
Brynn Kaczkofsky
Favorite
Kage, Hidenori

The University of Tokyo, Department of Respiratory Medicine
(P 103) BRAF MUTATIONS AND CONCURRENT ALTERATIONS IN PATIENTS WITH SOFT TISSUE SARCOMA
Hidenori Kage
Favorite
Kahraman, Abdullah

SwissSarcomaNetwork
(P 184) A SYSTEMATIC REVIEW ABOUT CLINICAL PROGNOSTIC MODELS FOR SARCOMAS
Abdullah Kahraman
Favorite
Kakunaga, Shigeki

Osaka International Cancer Institute
(P 05) DEVELOPMENT OF SARCOMA ORGANOID MODELS WITH AIR-LIQUID INTERFACE ORGANOID CULTURES
Shigeki Kakunaga
Favorite
(P 96) TRACP-5B AS A BIOMARKER FOR LONG-TERM DENOSUMAB TREATMENT OF UNRESECTABLE GIANT CELL TUMOR OF BONE
Shigeki Kakunaga
Favorite
(P 272) OUTCOMES OF FOUR CASES OF TOTAL HIP ARTHROPLASTY (THA) WITH POROUS TANTALUM IMPLANT AFTER PARTIAL ACETABULAR RESECTION USING 3D PREOPERATIVE PLANNING FOR PELVIC BONE TUMORS
Shigeki Kakunaga
Favorite
(P 283) USE OF MIXED REALITY IN PELVIC BONE TUMOR RESECTION: FIVE CASE STUDY
Shigeki Kakunaga
Favorite
(P 387) SUCCESSFUL PAZOPANIB TREATMENT OF UNDIFFERENTIATED PLEOMORPHIC SARCOMA WITH COAMPLIFICATION OF PDGFRA, VEGFR2, AND KIT: A CASE REPORT
Shigeki Kakunaga
Favorite
Kalabus, James

Inhibrx Biosciences, Inc
(P 95) THE TETRAVALENT DEATH RECEPTOR 5 AGONIST OZEKIBART (INBRX-109) IN PATIENTS WITH CHONDROSARCOMA: UPDATED RESULTS FROM A PHASE 1 STUDY
James Kalabus
Favorite
Kamal, Kousha

University of Toronto
(P 326) CELL-FREE DNA AS A BIOMARKER FOR CELL DEATH AND TREATMENT RESPONSE IN ON-CHIP THREE-DIMENSIONAL SARCOMA TUMOR MODELS
Kousha Kamal
Favorite
KAMODA, Hiroto

Chiba Cancer Center
(P 275) RECONSTRUCTION WITH A BURCH-SCHNEIDER CAGE AFTER BONE AND SOFT TISSUUE TUMOR SURGERY
Hiroto KAMODA
Favorite
Kanahori, Masaya

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University
(P 203) IMPACT OF COVID-19 PANDEMIC ON BONE AND SOFT TISSUE SARCOMA PATIENTS' CONSULTATION AND DIAGNOSIS
Masaya Kanahori
Favorite
Kane, Kathleen

Bone Cancer Research Trust
(P 196) ESTABLISHING THE BONE CANCER RESEARCH TRUST'S PATIENT & PUBLIC INVOLVEMENT PANEL
Kathleen Kane
Favorite
Kang, H. Paco

Department of Orthopaedic Surgery, Keck School of Medicine of the University of Southern California
(P 197) EVALUATION OF REVIEWS OF ORTHOPAEDIC ONCOLOGISTS ON INSTITUITIONAL AND PATIENT REVIEW WEBSITES
H. Paco Kang
Favorite
Kang, Hakmook

Vanderbilt University Medical Center
(P 73) LONGER TIME INTERVAL BETWEEN NEOADJUVANT CHEMOTHERAPY AND SURGERY IS ASSOCIATED WITH DECREASED TUMOR PERCENT NECROSIS IN OSTEOSARCOMA
Hakmook Kang
Favorite
(P 264) INTRAOPERATIVE FROZEN BONE MARROW MARGINS: A HELP OR A HINDRANCE IN EWING SARCOMA RESECTION?
Hakmook Kang
Favorite
(P 265) IS THERE AN IDEAL STEM TO CANAL RATIO IN LOWER EXTREMITY ONCOLOGIC ENDOPROSTHESIS RECONSTRUCTION?
Hakmook Kang
Favorite
(P 268) LOWER TUMOR PERCENT NECROSIS IS ASSOCIATED WITH POSITIVE FINAL SURGICAL MARGINS IN OSTEOSARCOMA
Hakmook Kang
Favorite
(P 404) ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL FOR PATENTS WITH SOFT TISSUE SARCOMA OF THE EXTREMITY: A PROSPECTIVE, NON-RANDOMIZED, CONSECUTIVELY ENROLLED TRIAL
Hakmook Kang
Favorite
Kang, Mingu

Lunit
(P 123) ARTIFICIAL INTELLIGENCE-POWERED MITOSIS EVALUATION TO COMPLEMENT HUMAN MITOTIC RATE INTERPRETATION IN PREDICTING PROGNOSIS IN LIPOSARCOMA
Mingu Kang
Favorite
Kang, Yoon-Koo

Asan Medical Center, University of Ulsan College of Medicine
(P 181) UPDATED OVERALL SURVIVAL WITH RIPRETINIB VS SUNITINIB IN PATIENTS WITH SECOND-LINE ADVANCED GASTROINTESTINAL STROMAL TUMOR AND KIT EXON 11+17/18 MUTATIONS: CIRCULATING TUMOR DNA ANALYSIS FROM INTRIGUE
Yoon-Koo Kang
Favorite
Kaplan, Rosandra

National Cancer Institute
(P 414) TENOSYNOVIAL GIANT CELL TUMOR IN CHILDREN: INTERIM RESULTS FROM A PHASE 1 STUDY OF TURALIO®
Rosandra Kaplan
Favorite
Karadimas, Thomas

USF Health Morsani College of Medicine
(P 262) EVALUATION OF STAGED RESECTION WITH TEMPORIZING VAC OF SOFT TISSUE SARCOMAS
Thomas Karadimas
Favorite
Karadimas, Thomas

University of South Florida Morsani College of Medicine
(P 263) HEMI- VS. REVERSE SHOULDER ARTHROPLASTY OUTCOMES FOLLOWING PROXIMAL HUMERAL ONCOLOGIC RESECTION
Thomas Karadimas
Favorite
(P 347) CAN UPFRONT RADIOTHERAPY PRECLUDE THE NEED FOR OPERATIVE STABILIZATION IN IMPENDING EXTREMITY FRACTURES FROM LUNG CANCER METASTASES?
Thomas Karadimas
Favorite
Karakis, Carson

The Ohio State University
(P 136) TARGETING MIR-138-5P TO TREAT DEDIFFERENTIATED LIPOSARCOMA
Carson Karakis
Favorite
Karim-Kos, Henrike

Princess Máxima Center for pediatric oncology
(P 319) THE SURVIVAL DISPARITY BETWEEN CHILDREN AND ADOLESCENTS & YOUNG ADULTS WITH EWING SARCOMA IN THE NETHERLANDS DID NOT CHANGE SINCE THE 1990S DESPITE IMPROVED SURVIVAL: A POPULATION-BASED STUDY
Henrike Karim-Kos
Favorite
Karim, Rooshdiya

Royal Prince Alfred Hospital-Labs-Anatomical Pathology
(P 325) CAN PROTEOMICS PREDICT METASTATIC RELAPSE IN LEIOMYOSARCOMA? DEVELOPMENT OF AN 8 PROTEIN SIGNATURE IN A >350 SAMPLE STUDY INCLUDING A VALIDATION COHORT
Rooshdiya Karim
Favorite
Kashyap, Jayanth

University of Pittsburgh School of Medicine
(P 256) CHARACTERIZING ORTHOPAEDIC ONCOLOGIC POLYTRAUMAS: A COMPARISON OF PATIENTS UNDERGOING OPERATIVE FIXATION OF MULTIPLE LESIONS WITH THOSE WITH SOLITARY LESIONS
Jayanth Kashyap
Favorite
(P 258) COMPARING OUTCOMES FOLLOWING INTRALESIONAL VERSUS WIDE RESECTION PROCEDURES IN THE TREATMENT OF RENAL CELL CARCINOMA BONE METASTASES
Jayanth Kashyap
Favorite
(P 353) PREDICTING WOUND COMPLICATIONS FOLLOWING SOFT-TISSUE SARCOMA RESECTION AMONG PATIENTS WHO RECEIVED PRE-OPERATIVE RADIATION
Jayanth Kashyap
Favorite
Kasper, Bernd

University of Heidelberg, Mannheim University Medical Center, Mannheim Cancer Center (MCC)
(P 33) DESCRIPTIVE EVALUATION OF PATIENTS WITH DESMOID TUMOR AND CO-OCCURRING SOMATIC MUTATIONS OF CTNNB1 AND APC IN THE PHASE 3 DEFI TRIAL
Bernd Kasper
Favorite
Kasper, Bernd

Mannheim University Medical Center
(P 201) GLOBAL CROSS-SECTIONAL SURVEY ON SARCOMA DIAGNOSIS PATHWAY: A CURRENT STATE ANALYSIS
Bernd Kasper
Favorite
Kaths, Moritz

University Hospital Essen, Sarcoma Centre
(P 378) INGUINAL SARCOMAS - A RETROSPECTIVE ANALYSIS OF DIAGNOSIS, CLINICAL FEATURES, TREATMENT PATTERNS AND OUTCOMES (I-SARC): A STUDY BY TARPSWG
Moritz Kaths
Favorite
Kawaguchi, Kengo

Kyushu University
(P 203) IMPACT OF COVID-19 PANDEMIC ON BONE AND SOFT TISSUE SARCOMA PATIENTS' CONSULTATION AND DIAGNOSIS
Kengo Kawaguchi
Favorite
Kawai, Akira

National Cancer Center Hospital Japan
(P 134) REAL-WORLD CLINICAL OUTCOME OF NEOADJUVANT CHEMOTHERAPY FOR RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Akira Kawai
Favorite
(P 220) SPORTS ACTIVITIES IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT SURVIVORS OF MALIGNANT BONE SARCOMAS
Akira Kawai
Favorite
(P 249) TUMOR CELL DISAPPEARANCE FOLLOWING COVID-19 INFECTION IN A PATIENT WITH PLEOMORPHIC SPINDLE CELL SARCOMA: A CASE REPORT
Akira Kawai
Favorite
Kawamura, Miyuki

Hyogo Cancer Center
(P 168) EFFICACY OF LOW-DOSE IMATINIB IN A PATIENT WITH A GIST WITH KIT EXON 11 W557_K558 DELETION
Miyuki Kawamura
Favorite
Kazemi, Mobina

Arnie Charbonneau Cancer Institute
(P 422) COMPARISON OF ANNOTATION METHODS FOR PAN-SARCOMA SINGLE CELL DATA
Mobina Kazemi
Favorite
Keedy, Vicki

Vanderbilt Ingram Cancer Center
(P 47) A PHASE 2 STUDY OF OLAPARIB IN METASTATIC IDH1 AND IDH2 MUTANT CHONDROSARCOMAS
Vicki Keedy
Favorite
Keedy, Vicki

Vanderbilt University Medical Center
(P 199) FINANCIAL TOXICITY AMONG SARCOMA PATIENTS AND ASSOCIATED FACTORS
Vicki Keedy
Favorite
(P 297) ESTABLISHING A PEDIATRIC, ADOLESCENT AND YOUNG ADULT COHORT OF SARCOMA PATIENTS TO STUDY ONCOLOGIC AND NON-ONCOLOGIC OUTCOMES
Vicki Keedy
Favorite
Keegan, Theresa

University of California Davis
(P 205) MULTI-MODAL TREATMENT IS ASSOCIATED WITH IMPROVED SURVIVAL IN AYA PATIENTS WITH METASTATIC NON-RHABDOMYOSARCOMA SOFT TISSUE SARCOMA
Theresa Keegan
Favorite
(P 356) RADIATION PRACTICE PATTERNS AND OUTCOMES IN ADOLESCENT YOUNG ADULT PATIENTS WITH VISCERAL NON-RHABDOMYOSARCOMA SOFT TISSUE SARCOMA
Theresa Keegan
Favorite
Keisch, Martin

University of Miami
(P 346) BRACHYTHERAPY FOR SOFT TISSUE SARCOMA: MAINTAINING LOCAL CONTROL WHILE MINIMIZING COMPLICATIONS
Martin Keisch
Favorite
Keit, Emily

Moffitt Cancer Center
(P 347) CAN UPFRONT RADIOTHERAPY PRECLUDE THE NEED FOR OPERATIVE STABILIZATION IN IMPENDING EXTREMITY FRACTURES FROM LUNG CANCER METASTASES?
Emily Keit
Favorite
Kelany, Mohamed

Ain Shams University Faculty of Medicine
(P 191) CLINICOPATHOLOGICAL CHARACTERISTICS OF ANGIOSARCOMA AND THE RISK OF MULTIPLE PRIMARY MALIGNANCIES
Mohamed Kelany
Favorite
Kelly, Ciara

Memorial Sloan Kettering Cancer Center
(P 101) AN OPEN LABEL PHASE IIA STUDY EVALUATING THE PRELIMINARY EFFICACY OF INTRATUMORAL TIGILANOL TIGLATE (TT) IN ADVANCED AND/OR METASTATIC SOFT TISSUE SARCOMA (STS, NCT05755113)
Ciara Kelly
Favorite
(P 121) ACQUIRED CYCLIN D AMPLIFICATION IS A MECHANISM FOR RESISTANCE TO CDK4/6 INHIBITORS IN DEDIFFERENTIATED LIPOSARCOMA
Ciara Kelly
Favorite
(P 229) EXPRESSION OF TRANSPOSABLE ELEMENTS AND IKZF1 PREDICTS IMMUNE INFILTRATES IN SARCOMAS AND CORRELATES WITH OUTCOMES AFTER IMMUNE CHECKPOINT INHIBITION
Ciara Kelly
Favorite
Kenna, Emma

University of Michigan
(P 131) HETEROGENEITY OF THE IMMUNE MICROENVIRONMENT AND IMMUNOTHERAPY RESPONSE IN A DEDIFFERENTIATED LIPOSARCOMA MOUSE MODEL
Emma Kenna
Favorite
(P 341) THE EFFECTS OF ULTRASOUND-GUIDED HISTOTRIPSY ON SOFT TISSUE SARCOMA
Emma Kenna
Favorite
Keohan, Mary Lou

Memorial Sloan Kettering Cancer Center
(P 121) ACQUIRED CYCLIN D AMPLIFICATION IS A MECHANISM FOR RESISTANCE TO CDK4/6 INHIBITORS IN DEDIFFERENTIATED LIPOSARCOMA
Mary Lou Keohan
Favorite
(P 229) EXPRESSION OF TRANSPOSABLE ELEMENTS AND IKZF1 PREDICTS IMMUNE INFILTRATES IN SARCOMAS AND CORRELATES WITH OUTCOMES AFTER IMMUNE CHECKPOINT INHIBITION
Mary Lou Keohan
Favorite
Kephart, Ellen

University of California- Santa Cruz
(P 295) DEFINING OSTEOSARCOMA HETEROGENEITY: CONSENSUS CLUSTERING REVEALS GENE EXPRESSION SUBTYPES
Ellen Kephart
Favorite
Kersch, Cymon

Oregon Health and Science University
(P 359) RAPIDLY PROGRESSIVE, NON-METASTATIC, CUTANEOUS ANGIOSARCOMA OF FACE AND SCALP TREATED WITH HYPOFRACTIONATED RADIATION THERAPY: A CASE SERIES
Cymon Kersch
Favorite
Kessler, Peter

Maastricht University Medical Center
(P 42) RANKL-INHIBITION FOR GIANT CELL LESIONS OF THE JAW: A RETROSPECTIVE COHORT ANALYSIS
Peter Kessler
Favorite
Keung, Emily

MD Anderson Cancer Center
(P 130) HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RESECTABLE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA (DDLPS) TREATED WITH NEOADJUVANT CHECKPOINT BLOCKADE IN A RANDOMIZED PHASE II CLINICAL TRIAL.
Emily Keung
Favorite
(P 233) IMMUNE CLASSES OF LEIOMYOSARCOMA DRIVEN BY B CELL INFILTRATE AND CTLA4 EXPRESSION
Emily Keung
Favorite
(P 360) TREATMENT OF MALIGNANT PERIPHERAL NERVE SHEATH TUMOR WITH BROMODOMAIN EXTRA TERMINAL INHIBITOR (BETI) IN COMBINATION WITH RADIOTHERAPY
Emily Keung
Favorite
(P 378) INGUINAL SARCOMAS - A RETROSPECTIVE ANALYSIS OF DIAGNOSIS, CLINICAL FEATURES, TREATMENT PATTERNS AND OUTCOMES (I-SARC): A STUDY BY TARPSWG
Emily Keung
Favorite
Keymeulen, Kristien

Maastricht University Medical Center
(P 361) WOUND COMPLICATIONS AFTER SOFT TISSUE SARCOMA RESECTION: A SINGLE-CENTER RETROSPECTIVE ANALYSIS
Kristien Keymeulen
Favorite
Khalaj, Andrew

Dana-Farber Cancer Institute
(P 195) ENHANCING PARTICIPANT ENGAGEMENT IN A NOVEL PATIENT-PARTNERED CANCER GENOMICS RESEARCH EFFORT FOR RARE AND AGGRESSIVE SARCOMAS
Andrew Khalaj
Favorite
Khalili, Korosh

Princess Margaret Cancer Centre
(P 376) IMPACT OF SITE OF ORIGIN ON THE PROGNOSIS OF PATIENTS WITH PRIMARY RESECTABLE NON-UTERINE ABDOMINAL LEIOMYOSARCOMA
Korosh Khalili
Favorite
Khalil, Moustafa

Hospital Maisonneuve-Rosment, University of Montreal
(P 394) IDENTIFYING THE INTERACTOME OF THE ONCOGENIC FUSIONS OF SARCOMAS TO REVEAL NOVEL THERAPEUTIC TARGETS
Moustafa Khalil
Favorite
Khanna, Chand

Ethos Discovery
(P 115) PROSPECTIVE EVALUATION OF THORACOSCOPIC METASTASECTOMY IN DOGS: A NOVEL TRANSLATIONAL DRUG DEVELOPMENT PIPELINE TAGETING METASTATIC OSTEOSARCOMA
Chand Khanna
Favorite
(P 408) OSTEOMYC: A PHASE 2 PILOT STUDY TO EVALIATE THE SAFETY AND THE ANTITUMOR ACTIVITY OF THE MYC INHIBITOR OMO-103 ADMINISTERED INTRAVENOUSLY IN PATIENTS WITH ADVANCED HIGH GRADE OSTEOSARCOMA
Chand Khanna
Favorite
Khan, Omar

Cumming School of Medicine, University of Calgary
(P 174) INCIDENCE, TREATMENT PATTERNS, AND SURVIVAL OUTCOMES FOR ADULT PATIENTS WITH GASTROINTESTINAL STROMAL TUMOURS (GIST) IN ALBERTA, CANADA FROM 2008 - 2022.
Omar Khan
Favorite
Khan, Omar

Tom Baker Cancer Center
(P 293) CIC-REARRANGED SOFT TISSUE SARCOMAS: DOES CHEMOTHERAPY CHANGE NATURAL HISTORY AND PROGNOSIS? A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) STUDY
Omar Khan
Favorite
Khare, Mansi

University of California Santa Cruz, Molecular Cell and Developmental Biology, Genomics Institute
(P 156) PROFILING SYNOVIAL SARCOMA EXTRACELLULAR VESICLES FOR DIAGNOSTIC RNA BIOMARKERS
Mansi Khare
Favorite
KHNEISSER, Pierre

Gustave Roussy
(P 53) CHARACTERIZING THE SPATIAL TRANSCRIPTOMIC LANDSCAPE OF OSTEOSARCOMA FROM DIAGNOSIS TO RELAPSE
Pierre KHNEISSER
Favorite
Kholodovsky, Eric

University of Miami
(P 282) UNPLANNED RESECTION OF SOFT TISSUE SARCOMA: THE IMPACT OF RESIDUAL DISEASE IN RE-RESECTION SPECIMEN
Eric Kholodovsky
Favorite
(P 346) BRACHYTHERAPY FOR SOFT TISSUE SARCOMA: MAINTAINING LOCAL CONTROL WHILE MINIMIZING COMPLICATIONS
Eric Kholodovsky
Favorite
Khosroyani, Homma

OHSU Knight Cancer Institute
(P 177) PREDICTING THE IMATINIB RESPONSE OF PDGFRA EXON 18-MUTANT GASTROINTESTINAL STROMAL TUMOR USING IN VITRO MODELS
Homma Khosroyani
Favorite
Kim, Hak Jae

Seoul National University Hospital
(P 428) OLIGOMETASTASES IN EXTREMITY SOFT TISSUE SARCOMA : SUBTYPE-SPECIFIC ANALYSES OF CHARACTERISTICS AND OUTCOMES
Hak Jae Kim
Favorite
Kim, Han-soo

Seoul National University Hospital
(P 110) INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY OF PLEOMORPHIC RHABDOMYOSARCOMA (P-RMS), A PUSH PLATFORM STUDY: OUTCOME OF LOCALIZED AND ADVANCED DISEASE
Han-soo Kim
Favorite
(P 127) DEDIFFERENTIATED LIPOSARCOMA OF THE EXTREMITIES: A KOREAN MULTI-CENTER STUDY OF 107 CASES
Han-soo Kim
Favorite
(P 428) OLIGOMETASTASES IN EXTREMITY SOFT TISSUE SARCOMA : SUBTYPE-SPECIFIC ANALYSES OF CHARACTERISTICS AND OUTCOMES
Han-Soo Kim
Favorite
Kim, Jae-Weon

, Seoul National University College of Medicine, Seoul (Republic of Korea);
(P 372) ESGO, EURACAN AND GCIG UTERINE SARCOMA GUDLINES: THE FIRST GLOBAL CONSENSUS
Jae-Weon Kim
Favorite
Kim, June Hyuk

National Cancer Center
(P 127) DEDIFFERENTIATED LIPOSARCOMA OF THE EXTREMITIES: A KOREAN MULTI-CENTER STUDY OF 107 CASES
June Hyuk Kim
Favorite
Kim, Kyung Soo

Seoul National University Hospital
(P 428) OLIGOMETASTASES IN EXTREMITY SOFT TISSUE SARCOMA : SUBTYPE-SPECIFIC ANALYSES OF CHARACTERISTICS AND OUTCOMES
Kyung Soo Kim
Favorite
Kim, Miso

Seoul National University Hospital
(P 428) OLIGOMETASTASES IN EXTREMITY SOFT TISSUE SARCOMA : SUBTYPE-SPECIFIC ANALYSES OF CHARACTERISTICS AND OUTCOMES
Miso Kim
Favorite
Kim, Taehee

David Geffen School of Medicine, University of California, Los Angeles
(P 27) SUMO2 INHIBITION REVERSES ABERRANT EPIGENETIC REWIRING DRIVEN BY SYNOVIAL SARCOMA FUSION ONCOPROTEINS AND IMPAIRS SARCOMAGENESIS
Taehee Kim
Favorite
Kim, Wanlim

Asan Medical Center
(P 127) DEDIFFERENTIATED LIPOSARCOMA OF THE EXTREMITIES: A KOREAN MULTI-CENTER STUDY OF 107 CASES
Wanlim Kim
Favorite
Kim, Yongsung

Seoul National University Bundang Hospital
(P 127) DEDIFFERENTIATED LIPOSARCOMA OF THE EXTREMITIES: A KOREAN MULTI-CENTER STUDY OF 107 CASES
Yongsung Kim
Favorite
King, Caitlin

Chordoma Foundation
(P 425) EXPLORING MECHANISMS OF EGFR INHIBITOR RESISTANCE IN CHORDOMA
Caitlin King
Favorite
KINOSHITA, Hideyuki

Chiba Cancer Center
(P 275) RECONSTRUCTION WITH A BURCH-SCHNEIDER CAGE AFTER BONE AND SOFT TISSUUE TUMOR SURGERY
Hideyuki KINOSHITA
Favorite
Kirsch, David

Princess Margaret Cancer Centre
(P 15) HISTONE DEACETYLASE-3 PLAYS A ROLE IN THE METASTATIC POTENTIAL OF A SUBPOPULATION OF CELLS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
David Kirsch
Favorite
(P 301) GENOME-WIDE CRISPR/CAS9 VIABILITY SCREENS UNCOVER NOVEL GENETIC DEPENDENCIES IN CIC::DUX4 SARCOMA
David Kirsch
Favorite
(P 303) INVESTIGATING THE THERAPEUTIC POTENTIAL OF TRIPTOLIDE PRODRUG, MINNELIDE, AS A TREATMENT ALTERNATIVE FOR CIC-DUX4 SARCOMA
David Kirsch
Favorite
(P 352) OUTCOMES OF PRIMARY INTRATHORACIC SOFT TISSUE SARCOMA
David Kirsch
Favorite
Kirton, Laura

University of Birmingham
(P 60) DIAGNOSIS AND MANAGEMENT OF PAEDIATRIC EWING SARCOMA PATIENTS IN ENGLAND 2014-2017: A COMPARISON OF NATIONAL DATA WITH THE EURO-EWING 2012 CLINICAL TRIAL
Laura Kirton
Favorite
Kishi, Shingo

Nozaki Tokushukai Hospital
(P 85) PTEROSTILBENE SENSITIZES OSTEOSARCOMA CELLS TO KILLING BY C-MYC INHIBITORS
Shingo Kishi
Favorite
Kiyotani, Chikako

National Center for Child Health and Development
(P 220) SPORTS ACTIVITIES IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT SURVIVORS OF MALIGNANT BONE SARCOMAS
Chikako Kiyotani
Favorite
Klein, Alyssa

Boehringer Ingelheim Pharmaceuticals Inc
(P 133) REAL-WORLD ANALYSIS OF DEDIFFERENTIATED LIPOSARCOMA (DDLPS) IN A US COMMUNITY ONCOLOGY SETTING
Alyssa Klein
Favorite
Klein, Jessica

Vanderbilt University School of Medicine
(P 73) LONGER TIME INTERVAL BETWEEN NEOADJUVANT CHEMOTHERAPY AND SURGERY IS ASSOCIATED WITH DECREASED TUMOR PERCENT NECROSIS IN OSTEOSARCOMA
Jessica Klein
Favorite
(P 268) LOWER TUMOR PERCENT NECROSIS IS ASSOCIATED WITH POSITIVE FINAL SURGICAL MARGINS IN OSTEOSARCOMA
Jessica Klein
Favorite
Kleinman, Claudia

McGill university
(P 78) NOVEL EPIGENETIC MECHANISMS DRIVE AGGRESSIVE OSTEOSARCOMA PATHOGENESIS AND DRUG RESISTANCE
Claudia Kleinman
Favorite
Klein, Stefan

Erasmus Medical Center
(P 154) PREOPERATIVE CLASSIFICATION OF NERVE SHEATH TUMORS USING RADIOMICS-BASED MACHINE LEARNING
Stefan Klein
Favorite
Klemen, Nicholas

Surgery Branch, NCI, NIH
(P 231) IDENTIFICATION OF NEOANTIGEN FROM PECOMA-LIKE NEOPLASM PROVIDES RATIONALE FOR TREATMENT WITH CELLULAR THERAPY
Nicholas Klemen
Favorite
Klimeš Lipánová, Michaela

Department of Oncology, 2nd Medical Faculty, Charles University and University Hospital Motol Proton Therapy Center Czech, s.r.o.
(P 355) PROTON RADIOTHERAPY FOR DESMOID TUMORS: A SINGLE-CENTER EXPERIENCE
Michaela Klimeš Lipánová
Favorite
KLop, Cornelis

Amsterdam University Medical Center
(P 42) RANKL-INHIBITION FOR GIANT CELL LESIONS OF THE JAW: A RETROSPECTIVE COHORT ANALYSIS
Cornelis KLop
Favorite
Klymchenko, Andrey

UMR7021 CNRS -Laboratory of Bioimaging and Pathologies
(P 75) METABOLIC EVALUATION OF THE RELATIONSHIP BETWEEN MACROPHAGES AND OSTEOSARCOMA TUMOR CELLS
Andrey Klymchenko
Favorite
Knab, Tim

Metrum Research Group
(P 116) QUANTITATIVE SYSTEMS PHARMACOLOGY MODELING OF MIPASETAMAB UZOPTERINE INTEGRATES KNOWLEDGE AND DEFINES DOSING STRATEGY FOR PATIENTS WITH SARCOMA
Tim Knab
Favorite
Knight, James

School of Natural and Environmental Sciences, Newcastle University, UK
(P 22) MECHANISMS OF PREFERENTIAL TUMOUR UPTAKE OF INDOCYANINE GREEN IN SARCOMA
James Knight
Favorite
Kobayashi, Eisuke

Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital
(P 134) REAL-WORLD CLINICAL OUTCOME OF NEOADJUVANT CHEMOTHERAPY FOR RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Eisuke Kobayashi
Favorite
(P 249) TUMOR CELL DISAPPEARANCE FOLLOWING COVID-19 INFECTION IN A PATIENT WITH PLEOMORPHIC SPINDLE CELL SARCOMA: A CASE REPORT
Eisuke Kobayashi
Favorite
Kobayashi, Hiroshi

The University of Tokyo Hospital
(P 57) CLINICAL GENOMIC PROFILING OF MALIGNANT GIANT CELL TUMOR OF BONE: A RETROSPECTIVE ANALYSIS USING A REAL-WORLD DATABASE
Hiroshi Kobayashi
Favorite
(P 103) BRAF MUTATIONS AND CONCURRENT ALTERATIONS IN PATIENTS WITH SOFT TISSUE SARCOMA
Hiroshi Kobayashi
Favorite
(P 220) SPORTS ACTIVITIES IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT SURVIVORS OF MALIGNANT BONE SARCOMAS
Hiroshi Kobayashi
Favorite
Kobbeltvedt, Marthe Rosvoll

Oslo University Hospital
(P 40) PEGYLATED LIPOSOMAL DOXORUBICIN IN SYMPTOMATIC DESMOID TUMOR
Marthe Rosvoll Kobbeltvedt
Favorite
Koch, Regina

Mayo Clinic
(P 120) USING AI PREDICTIONS FROM ECG TRACINGS TO PREDICT TOLERANCE TO ANTHRACYCLINE CHEMOTHERAPY IN SARCOMA
Regina Koch
Favorite
Ko, Christine

Yale University
(P 98) A MULTIEPITOPE MRNA VACCINE FOR KAPOSI SARCOMA: AN IMMUNOINFORMATIC APPROACH
Christine Ko
Favorite
Kocsis, Jenna

Cleveland Clinic
(P 351) OSTEOSARCOMA STEREOTACTIC BODY RADIOTHERAPY: OUTCOMES AND PATTERN OF FAILURE
Jenna Kocsis
Favorite
Koh, Andrew

University of Texas Southwestern Medical Center
(P 417) VITAS: ATEZOLIZUMAB IN COMBINATION WITH CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY SOLID TUMORS: AN OPEN-LABEL, PHASE I/II, SINGLE-ARM, MULTI-CENTER TRIAL IN PROGRESS
Andrew Koh
Favorite
Koh, Jennifer

ProCan, Children’s Medical Research Institute
(P 325) CAN PROTEOMICS PREDICT METASTATIC RELAPSE IN LEIOMYOSARCOMA? DEVELOPMENT OF AN 8 PROTEIN SIGNATURE IN A >350 SAMPLE STUDY INCLUDING A VALIDATION COHORT
Jennifer Koh
Favorite
Koike, Hiroshi

Nagoya University Hospital
(P 280) SURGICAL OUTCOMES OF PELVIC CHONDROSARCOMA WITH A FOCUS ON WALKING ABILITY
Hiroshi Koike
Favorite
KOLLENDER, YEHUDA

The Israeli Orthopedic Oncology Center
(P 182) A NOVEL MODEL FOR THE DIRECT REFERRAL OF ONCOLOGIC PATIENTS IN A PUBLIC HEALTH CARE SYSTEM
YEHUDA KOLLENDER
Favorite
(P 252) A NOVEL MULTIDISCIPLINARY SURGICAL APPROACH TO PERIPHERAL NERVE SHEATH TUMORS AND SOFT TISSUE SARCOMAS.
YEHUDA KOLLENDER
Favorite
Komiyama, Motokiyo

Department of Urology, National Cancer Center Hospital, Tokyo, Japan
(P 134) REAL-WORLD CLINICAL OUTCOME OF NEOADJUVANT CHEMOTHERAPY FOR RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Motokiyo Komiyama
Favorite
Kondo, Hiroya

National Cancer Center Hospital
(P 249) TUMOR CELL DISAPPEARANCE FOLLOWING COVID-19 INFECTION IN A PATIENT WITH PLEOMORPHIC SPINDLE CELL SARCOMA: A CASE REPORT
Hiroya Kondo
Favorite
Koneru, Balakrishna

Texas Tech University Health Sciences Center
(P 292) CHARACTERIZATION OF TELOMERE MAINTENANCE MECHANISMS IN OSTEOSARCOMA PATIENT-DERIVED LABORATORY MODELS
Balakrishna Koneru
Favorite
Koo, Selene

St. Jude Children's Research Hospital
(P 288) ANGIOA: A SAFETY AND TOLERABILITY STUDY OF TRIPLE ANTI-ANGIOGENIC THERAPY COMBINED WITH PD-L1 BLOCKADE IN PEDIATRIC, ADOLESCENT AND YOUNG ADULT RECURRENT/REFRACTORY SOLID TUMORS
Selene Koo
Favorite
Kopečková, Kateřina

2nd Medical Faculty, Charles University and University Hospital Motol
(P 355) PROTON RADIOTHERAPY FOR DESMOID TUMORS: A SINGLE-CENTER EXPERIENCE
Kateřina Kopečková
Favorite
Kopeld, Jacob

Atlantic Health System
(P 255) CAN LARGE, LIPOMATOUS LESIONS ADJACENT TO THE SUPINATOR MUSCLE BE REMOVED WITHOUT INJURING THE POSTERIOR INTEROSSEOUS NERVE? A RETROSPECTIVE REVIEW
Jacob Kopeld
Favorite
(P 260) EMERGING TECHNOLOGY IN ORTHOPEDIC ONCOLOGY: ROBOTIC ARM-ASSISTED TOTAL KNEE ARTHROPLASTY HAS EXCEPTIONAL FUNCTION OUTCOMES FOR PATIENTS WITH BENIGN AND MALIGNANT MUSCULOSKELETAL DISEASE
Jacob Kopeld
Favorite
(P 266) LONG STEM CEMENTED ROBTIC ARM-ASSISTED TOTAL HIP ARTHROPLASTY: OUTCOMES IN PATIENTS WITH PRIOR ONCOLOGIC DISEASE
Jacob Kopeld
Favorite
(P 277) REVERSE TOTAL SHOULDER ARTHROPLASTY MAINTAINS GLOBAL FUNCTION OF THE UPPER EXTREMITY IN PATIENTS WITH ONCOLOGIC DISEASE OF THE PROXIMAL HUMERUS
Jacob Kopeld
Favorite
(P 405) LIPOSOMAL BUPIVACAINE DOESN'T REDUCE NARCOTIC USE OR PAIN SCORES COMPARED TO A MULTIDRUG COCKTAIL FOLLOWING SOFT TISSUE TUMOR REMOVAL: PRELIM RESULTS OF A PROSPECTIVE, RANDOMIZED DOUBLE-BLINDED STUDY
Jacob Kopeld
Favorite
Koppenhafer, Stacia

University of Iowa
(P 14) HDAC INHIBITORS DOWNREGULATE THE EXPRESSION LEVELS OF THE MINI-CHROMOSOME MAINTENANCE PROTEINS, AND INHIBIT DNA REPLICATION, IN EWING SARCOMA CELLS
Stacia Koppenhafer
Favorite
Korleski, John

Mayo Clinic
(P 120) USING AI PREDICTIONS FROM ECG TRACINGS TO PREDICT TOLERANCE TO ANTHRACYCLINE CHEMOTHERAPY IN SARCOMA
John Korleski
Favorite
Koyama, Tatsuki

Vanderbilt University Medical Center
(P 199) FINANCIAL TOXICITY AMONG SARCOMA PATIENTS AND ASSOCIATED FACTORS
Tatsuki Koyama
Favorite
(P 297) ESTABLISHING A PEDIATRIC, ADOLESCENT AND YOUNG ADULT COHORT OF SARCOMA PATIENTS TO STUDY ONCOLOGIC AND NON-ONCOLOGIC OUTCOMES
Tatsuki Koyama
Favorite
Kozak, Katarzyna

Maria Sklodowska-Curie National Research Institute of Oncology
(P 245) PRELIMINARY RESULTS FROM A PHASE 2 EFTISARC-NEO TRIAL OF NEOADJUVANT SOUBLE LAG-3 PROTEIN EFTILAGIMOD ALPHA, PEMBROLIZUMAB, AND CONCURRENT RADIOTHERAPY IN PATIENTS WITH RESECTABLE SOFT TISSUE SARCOMA
Katarzyna Kozak
Favorite
Kozlowski, Erin

SARC
(P 102) ANALYSIS OF BLOOD-BASED BIOMARKERS AS PROGNOSTIC FACTORS IN PATIENTS WITH EHE TREATED WITH TRAMETINIB IN SARC033
Erin Kozlowski
Favorite
Kozlowski, Konrad

University of Miami Miller School of Medicine
(P 369) BLAND EMBOLIZATION AS ADJUNCT TREATMENT FOR HEPATIC EPITHELIOID HEMANGIOENDOTHELIOMA
Konrad Kozlowski
Favorite
Krailo, Mark

Keck School of Medicine of the University of Southern California
(P 06) DIFFICULTIES IN ASSESSING THE PROGNOSTIC SIGNIFICANCE OF A NOVEL BIOMARKER IN THE CONTEXT OF A TISSUE BANKING STUDY
Mark Krailo
Favorite
Krailo, Mark

Childrens Oncology Group
(P 50) ANALYSIS OF CLINICAL FEATURES AND OUTCOMES FOR PATIENTS WITH MULTIFOCAL OSTEOSARCOMA: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Mark Krailo
Favorite
Kramer, Jeffrey

Chondrosarcoma Foundation
(P 55) CHONDROSARCOMA PATIENT CHARACTERISTICS AND DIAGNOSTIC AND TREATMENT PATHWAYS: GLOBAL CHONDROSARCOMA PATIENT REGISTRY
Jeffrey Kramer
Favorite
Krarup-Hansen, Anders

Department of Oncology, Copenhagen University Hospital, Herlev & Gentofte Hospital
(P 29) ABDOMINAL LYMPHANGIOMA CAUSING EXCESSIVE GASTROINTESTINAL BLEEDING FOR MORE THAN TWO DECADES
Anders Krarup-Hansen
Favorite
(P 104) CIRQUESARC: A NATIONAL PROSPECTIVE OBSERVATIONAL STUDY OF CIRCULATING TUMOR DNA AND QUALITY OF LIFE IN PATIENTS WITH SARCOMA – PRELIMINARY RESULTS FROM THE SURGICAL COHORT
Anders Krarup-Hansen
Favorite
(P 243) MYELOSUPPRESSION FOLLOWING LYMPHODEPLETING CHEMOTHERAPY AS PART OF ADOPTIVE CELL THERAPY FOR PATIENTS WITH PROGRESSIVE SOFT TISSUE SARCOMA AFTER STANDARD CHEMOTHERAPY
Anders Krarup-Hansen
Favorite
(P 411) PROPANE AN OPEN LABEL PHASE 2 STUDY ON PROPRANOLOL AND PEMBROLIZUMAB IN ADVANCED ANGIOSARCOMA AND UNDIFFERENTIATED PLEOMORPHIC SARCOMA A SCANDINAVIAN SARCOMA GROUP COLLABORATION
Anders Krarup-Hansen
Favorite
Krawetz, Roman

McCaig Institute for Bone and Joint Health
(P 327) CHARACTERIZATION OF TWO NOVEL IMMUNE COMPETENT, MURINE MODELS OF SOFT TISSUE SARCOMA
Roman Krawetz
Favorite
Krez, Alexandra

Duke University School of Medicine
(P 54) CHONDROBLASTIC OSTEOSARCOMA IS A RISK FACTOR FOR LOCAL RECURRENCE IN PATIENTS WITH SKELETAL OSTEOSARCOMA
Alexandra Krez
Favorite
Krishnan, Chandra Kumar

Cancer Institute (WIA)
(P 61) DOES CLINICAL PROGRESSION PORTEND POOR ONCOLOGICAL OUTCOMES IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY
Chandra Kumar Krishnan
Favorite
(P 67) EXTERMITY SOFT TISSUE SARCOMA -RETROSPECTIVE ANALYSIS OF 21YEARS EXPERIENCE IN A TERTITARY CARE CENTRE.
Chandra Kumar Krishnan
Favorite
(P 84) PROGNOSTIC IMPLICATIONS OF PATHOLOGICAL FRACTURES IN EXTREMITY OSTEOSARCOMA: A RETROSPECTIVE ANALYSIS OF SURVIVAL OUTCOMES AND LIMB-SALVAGE FEASIBILITY
Chandra Kumar Krishnan
Favorite
(P 105) CLINICAL OUTCOMES OF SUB-CENTIMETRIC LUNG NODULES IN PATIENTS WITH EXTREMITY OSTEOSARCOMA: A RETROSPECTIEV COHORT STUDY
Chandra Kumar Krishnan
Favorite
(P 198) FACTORS INFLUENCING TIME TO TREATMENT INITIATION IN PROMARY EXTREMITY SARCOMA: A RETROSPECTIVE ANALYSIS
Chandra Kumar Krishnan
Favorite
Kristiansson, Ingvar

Dpt of Radiology, Skane University Hospital, Lund, Sweden
(P 286) ADAMANTINOMA - LIKE EWING SARCOMA WITH ATYPICAL PRESENTATION AND FATAL OUTCOME IN 20-YEAR-OLD WOMAN - A CASE REPORT
Ingvar Kristiansson
Favorite
Kruiswijk, Anouk

Leiden University Medical Center
(P 194) EFFECTIVENESS OF A RISK PREDICTION TOOL (PERSARC) ON THE QUALITY OF TREATMENT DECISIONS IN SOFT-TISSUE SARCOMA PATIENTS (VALUE-PERSARC TRIAL)
Anouk Kruiswijk
Favorite
Kubeš, Jiří

Proton Therapy Center Czech, s.r.o.
(P 355) PROTON RADIOTHERAPY FOR DESMOID TUMORS: A SINGLE-CENTER EXPERIENCE
Jiří Kubeš
Favorite
Kubicki, Natalie

Duke University
(P 16) HOW TO GROW A BONE IN 60 DAYS: EXPLORING THE UNIQUE PRO-GROWTH, ANTI-CANCER ENVIRONMENT IN ELK ANTLERS
Natalie Kubicki
Favorite
Kucharik, Michael

USF Morsani College of Medicine
(P 263) HEMI- VS. REVERSE SHOULDER ARTHROPLASTY OUTCOMES FOLLOWING PROXIMAL HUMERAL ONCOLOGIC RESECTION
Michael Kucharik
Favorite
Kuijpers, Anke

Netherlands Cancer Institute/ Antoni van Leeuwenhoek
(P 24) NEOADJUVANT CHEMOTHERAPY FOR RADIOTHERAPY ASSOCIATED ANGIOSARCOMA (RAAS) OF THE BREAST IMPROVES ONCOLOGICAL OUTCOMES
Anke Kuijpers
Favorite
Kuleshov, Nikol

CHU de Québec - Université Laval
(P 153) PATTERNS, MANAGEMENT AND SURVIVAL OUTCOMES OF PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A NATIONWIDE ANALYSIS FROM THE CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION DATABASE
Nikol Kuleshov
Favorite
(P 320) WHAT IS THE ROLE OF CHEMOTHERAPY IN PATIENTS (PTS) WITH SPINDLE CELL/SCLEROSING RHABDOMYOSARCOMA (SCRMS): A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) STUDY
Nikol Kuleshov
Favorite
Kumar, Anand

6Department of Radiology, Massachusetts General Hospital
(P 22) MECHANISMS OF PREFERENTIAL TUMOUR UPTAKE OF INDOCYANINE GREEN IN SARCOMA
Anand Kumar
Favorite
Kumar, Jessica

University of Miami Miller School of Medicine
(P 369) BLAND EMBOLIZATION AS ADJUNCT TREATMENT FOR HEPATIC EPITHELIOID HEMANGIOENDOTHELIOMA
Jessica Kumar
Favorite
Kumar, Sonia

IRCCS Humanitas Research Hospital
(P 373) EVALUATION OF HISTOLOGIC ORGAN INFILTRATION (HOI) AND VISCERAL RESECTION MARGINS (VRM) IN PRIMARY RETROPERITONEAL SARCOMAS: PROGNOSTIC IMPLICATIONS FOR LOCAL RECURRENCE
Sonia Kumar
Favorite
(P 389) THE ROLE OF NUTRITIONAL STATUS ON POSTOPERATIVE AND ONCOLOGICAL OUTCOMES IN RETROPERITONEAL SARCOMA
Sonia Kumar
Favorite
Kummar, Shivaani

Oregon Health & Science University
(P 396) LONG-TERM FOLLOW-UP EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
Shivaani Kummar
Favorite
Kung, Andrew

Memorial Sloan Kettering Cancer Center
(P 338) PRECLINICAL EFFICACY OF DAN-222, A NOVEL POLYMERIC NANOPARTICLE, IN PEDIATRIC SOLID TUMOR MODELS
Andrew Kung
Favorite
(P 418) A SYSTEMS BIOLOGY APPROACH FOR CHARACTERIZING TUMOR HETEROGENEITY AND CELL STATE-SPECIFIC THERAPEUTIC VULNERABILITIES FROM SINGLE NUCLEUS RNA-SEQ PROFILING OF DESMOPLASTIC SMALL ROUND CELL TUMORS
Andrew Kung
Favorite
Kuniyasu, Hiroki

Nara Medical University
(P 85) PTEROSTILBENE SENSITIZES OSTEOSARCOMA CELLS TO KILLING BY C-MYC INHIBITORS
Hiroki Kuniyasu
Favorite
Kunning, Sheryl

UPMC Department of Immunology and Hillman Cancer Center
(P 240) INVESTIGATING MACROPHAGE POPULATION VARIABILITY IN METASTATIC SARCOMA SAMPLES
Sheryl Kunning
Favorite
Kuo, Christopher

Children's Hospital Los Angeles
(P 76) MOLECULAR AND CHROMOSOMAL MICROARRAY PROFILING OF OSTEOSARCOMA IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS: A SINGLE INSTITUTION REPORT
Christopher Kuo
Favorite
(P 88) SPATIAL TRANSCRIPTOMICS OF EWING SARCOMA: EVOLUTION OF TUMOR MICROENVIRONMENT ASSOCIATED EXTRACELLULAR MATRIX FROM LOCALIZED TO METASTASIS-ASSOCIATED PRIMARY TUMORS
Christopher Kuo
Favorite
Kuruvilla, Davis

University of South Florida Morsani College of Medicine
(P 257) COMPARATIVE OUTCOMES OF CONSTRAINED ACETABULAR LINERS VS. DUAL MOBILITY CUPS IN COMPLEX HIP RECONSTURCTION FOR METASTATIC BONE DISEASE
Davis Kuruvilla
Favorite
(P 279) SIGNIFICANCE OF TIP-APEX DISTANCE IN ACTUAL AND IMPENDING PATHOLOGICAL FRACTURES OF THE PROXIMAL FEMUR
Davis Kuruvilla
Favorite
Kusakawa, Halu

Sarcoma Oncology Center
(P 106) DELTAREX-G, A TUMOR TARGETED CCNG1 INHIBITOR, DEMONSTRATES CLINICAL BENEFIT IN ADVANCED CHEMORESISTANT SARCOMA FOLLOWING FDA CBER AUTHORIZATION FOR USE AS PLATFORM THERAPY WITH FDA APPROVED DRUGS
Halu Kusakawa
Favorite
Kyrysyuk, Sasha

Yale University
(P 98) A MULTIEPITOPE MRNA VACCINE FOR KAPOSI SARCOMA: AN IMMUNOINFORMATIC APPROACH
Sasha Kyrysyuk
Favorite